Articles on methods, technologies, and analysis techniques for single B cell antibody screening.
Explore how Biointron’s AbDrop™ platform combines microfluidics, single B cell screening, and NGS to accelerate antibody discovery and therapeutic development.
AbDrop™ isolates diverse, high-affinity antibodies rapidly. Biointron shows how this platform transforms discovery with speed, scale, and precision.
Single B cell screening accelerates discovery. Biointron demonstrates how this technology identifies potent antibodies faster, guiding therapeutic development.
You can also contact us on the Scientist and Science Exchange marketplaces.